Characterization of field‐evolved resistance to Bacillus thuringiensis ‐derived Cry1F δ‐endotoxin in Spodoptera frugiperda populations from Argentina
Year: 2017
Type: article
Abstract: BACKGROUND Transgenic maize ( Zea mays L.) event TC1507 (Herculex ® I insect protection), expressing Cry1F δ‐endotoxin derived from Bacillus thuringiensis var. aizawai , was commercialized in 2003 in the Americas. Spodoptera frugiperda (J.E. Smith) (Lepidoptera: Noctuidae) susceptibility to Cry1F was monitored annually across several regions in Argentina using diagnostic concentration bioassays. Reduced performance of TC1507 maize against S. frugiperda was reported in 2013. A resistant population was established in the laboratory and the dominance of Cry1F resistance was characterized. RESULTS During 2012–2015, high‐survivorship of several populations was observed in the resistance monitoring program. Reciprocal crosses of a Cry1F‐resistant population with a Cry1F‐susceptible population were evaluated to calculate effective dominance (D ML ) based on mortality levels observed at 100 µg/ml Cry1F. Two additional dominance levels (D LC and D EC ) were calculated using lethal (LC 50 ) or effective concentration (EC 50 ) derived from concentration–response bioassays. Estimates indicated that Cry1F resistance in S. frugiperda in Argentina was either highly recessive (D ML = 0.005) or incompletely recessive (D LC < 0.26 and D EC < 0.19). CONCLUSION This study is the first documented confirmation and characterization of S. frugiperda Cry1F field‐evolved resistance in Argentina. The resistance to Cry1F in S. frugiperda populations collected in Argentina, is autosomal and incompletely recessive similar to the resistance reported in Brazil. © 2017 Dow AgroSciences LLC. Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
Source: Pest Management Science
DOI: 10.1002/ps.4776
Institution: Pioneer Hi-Bred
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
SDG: Zero hunger
Open Access status: hybrid
Estimated APC paid: $5,360
Funder: Dow Chemical Company
OpenAlex ID: W2767170035
